Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2020, Issue -, Pages 1-17
Publisher
Hindawi Limited
Online
2020-01-14
DOI
10.1155/2020/2514090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non–Small-Cell Lung Cancer
- (2018) Keqiang Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells
- (2018) Keiichiro Sakuma et al. CANCER SCIENCE
- Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells
- (2018) Lingfeng He et al. DNA REPAIR
- New trials and results in systemic treatment of HCC
- (2018) María Reig et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner
- (2018) Jordan R Becker et al. NUCLEIC ACIDS RESEARCH
- Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression
- (2018) Jiao Zou et al. Oncotarget
- Distinct Mechanisms of Nuclease-Directed DNA-Structure-Induced Genetic Instability in Cancer Genomes
- (2018) Junhua Zhao et al. Cell Reports
- HBV infection and HCC: the ‘dangerous liaisons’
- (2017) Antonio Bertoletti et al. GUT
- Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening
- (2017) Amit Laxmikant Deshmukh et al. Molecular BioSystems
- FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
- (2017) Lingfeng He et al. Molecular Oncology
- Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression
- (2016) Lingfeng He et al. EBioMedicine
- Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China
- (2015) Xingyuan Jiao et al. Scientific Reports
- The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma
- (2015) Jau-Chung Hwang et al. PLoS One
- Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis
- (2014) KEJIA WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
- (2014) Tarek M.A. Abdel-Fatah et al. Molecular Oncology
- ANEIL1single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy
- (2013) Yun Chen et al. CANCER
- Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population
- (2013) Wen-Qing Li et al. CARCINOGENESIS
- Functional FEN1 genetic variants and haplotypes are associated with glioma risk
- (2012) Yi-Dong Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer
- (2011) L. Liu et al. CARCINOGENESIS
- Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
- (2011) A Urbanucci et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started